Advertisement

Topics

Arachnova Limited Company Profile

08:25 EDT 24th September 2017 | BioPortfolio

Arachnova is a virtual R&D based pharmaceutical company and a pioneer of therapeutic switching (finding new therapeutic uses for existing drugs). Two important projects are in early stage clinical trials. The first is in stress urinary incontinence, the second in dermatitis — both potentially large but under-researched disease areas in need of better therapies.Therapeutic Switching — an opportunity for partnership

Arachnova has an unparalleled capability to find new uses for existing compounds, and has used this capability to generate its own patent-protected projects. It is based on a unique way of looking at drug discovery, on extensive partnerships with academic investigators and on SwitchBasetm, its proprietary database. SwitchBasetm is an exclusive database that links known compounds to potential new uses that are being discovered, for instance, from the company's own research and from the revelations of new biology. The benefit of this expertise and technology is offered to others in the pharmaceutical industry. Arachnova offers a no-fee evaluation on the basis that it is typically expected to produce patentable licence and/or development opportunities in partnership. Arachnova is in a position to take suitable projects through to clinical proof-of-principle with its own resources.

Experts in project leadership, evaluation and outsourcing

The experience of the team, their proven track record in successful R&D and bringing compounds speedily through clinical trials makes Arachnova a highly valuable partner.

Arachnova is expert at project leadership and outsourced project management. Retained as consultants to instigate and implement projects for a range of companies, work has encompassed all stages of the development process. The company's Technology Web(tm) is a vast database of service providers that can add value during the discovery and development process, and is available through www.arachnova.com/search.

Many clients and project partners are already reaping the benefits that this approach can bring — faster development times with lower costs and reduced risk. It is significant, and a testament to the capabilities of the Arachnova team, that clients regularly commission additional assignments. In addition to consultancy on project leadership and management Arachnova works in other areas including the provision of expert opinion, preparation of expert reports and the completion of due diligence projects.

Location

St John's Innovation Centre
Cambridge
Cambridgeshire
CB4 0WS
United Kingdom

Contact

Phone: 44 1223 722793
Fax: 44 1223 722793


News Articles [13 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Arachnova

Arachnova has a focus on therapeutic switches, namely new uses for known drugs, and alternatively called 'drug reprofiling', 'drug repositioning' or 'drug repurposing'.Our approach is therapeutically ...

Arachnova Limited

Arachnova is a virtual R&D based pharmaceutical company and a pioneer of therapeutic switching (finding new therapeutic uses for existing drugs). Two important projects are in early stage clinical tri...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Arachnova Limited" on BioPortfolio

We have published hundreds of Arachnova Limited news stories on BioPortfolio along with dozens of Arachnova Limited Clinical Trials and PubMed Articles about Arachnova Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arachnova Limited Companies in our database. You can also find out about relevant Arachnova Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Stress
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...


Corporate Database Quicklinks



Searches Linking to this Company Record